Syndax Pharmaceuticals, Inc. (SNDX): Price and Financial Metrics

SNDX POWR Grades

• Value is the dimension where SNDX ranks best; there it ranks ahead of 68.74% of US stocks.
• The strongest trend for SNDX is in Quality, which has been heading up over the past 26 weeks.
• SNDX's current lowest rank is in the Momentum metric (where it is better than 4.71% of US stocks).

SNDX Stock Summary

• The ratio of debt to operating expenses for SYNDAX PHARMACEUTICALS INC is higher than it is for about only 5.1% of US stocks.
• With a year-over-year growth in debt of -94.19%, SYNDAX PHARMACEUTICALS INC's debt growth rate surpasses just 1.3% of about US stocks.
• As for revenue growth, note that SNDX's revenue has grown 836.77% over the past 12 months; that beats the revenue growth of 98.77% of US companies in our set.
• Stocks that are quantitatively similar to SNDX, based on their financial statements, market capitalization, and price volatility, are RXDX, PSTX, IDYA, ALPN, and BOLT.
• SNDX's SEC filings can be seen here. And to visit SYNDAX PHARMACEUTICALS INC's official web site, go to www.syndax.com.

SNDX Valuation Summary

• SNDX's price/sales ratio is 12.4; this is 148% higher than that of the median Healthcare stock.
• Over the past 85 months, SNDX's price/sales ratio has gone down 320.3.

Below are key valuation metrics over time for SNDX.

SNDX Growth Metrics

The year over year revenue growth rate now stands at 9090.63%.
• Its 3 year price growth rate is now at 91.27%.
• Its 2 year revenue growth rate is now at 9090.63%.

SNDX's revenue has moved up $125,060,000 over the prior 15 months.

The table below shows SNDX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	126.576	-10.072	-13.946
2022-06-30	138.951	-6.472	0.818
2022-03-31	139.33	9.789	15.48
2021-12-31	139.709	29.131	24.926
2021-09-30	13.512	-87.209	-91.695
2021-06-30	1.516	-80.562	-91.493

SNDX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• SNDX has a Quality Grade of D, ranking ahead of 17.57% of graded US stocks.
• SNDX's asset turnover comes in at 0.006 -- ranking 405th of 682 Pharmaceutical Products stocks.
• SYRS, LFVN, and ICPT are the stocks whose asset turnover ratios are most correlated with SNDX.

The table below shows SNDX's key quality metrics over time.